Discover how gut bacteria may influence multiple sclerosis progression and severity. Research reveals specific bacterial ...

MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...

The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare ...

Black people with MS walk slower and cover shorter distances than white patients, even when some social determinants are ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

Scientists from Sweden’s Karolinska Institutet have uncovered new clues about how the Epstein-Barr virus (EBV) might ...

Data show minimal risk of stopping DMTs in older MS patients with stable disease. Now, the focus has shifted to understanding ...

Machine learning is driving efforts to classify MS into distinct subtypes that may predict disease course, but two experts debate whether this will advance patient care.

The ratio of two types of bacteria in the gut microbiome may be able to predict disease severity in multiple sclerosis, ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...